🇺🇸 FDA
Pipeline program

100mg diclofenac

KY20232165-C-1

Unknown small_molecule terminated

Quick answer

100mg diclofenac for Post-ERCP Acute Pancreatitis is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Post-ERCP Acute Pancreatitis
Phase
Unknown
Modality
small_molecule
Status
terminated

Clinical trials